Kooij Louise FrederikaCAO
Sell $2.3M of disclosed value in NewAmsterdam Pharma Company N.V. $NAMS.
Sell
GLP-1 & Metabolic Health
- Last updated
- Jul 20, 2026
- Based on
- 226 actions
- Gurus considered
- 148
- Stocks covered
- 170
Obesity, diabetes, GLP-1, and metabolic disease exposure. This page tracks 226 investor, Congress, and insider actions tied to GLP-1 & Metabolic Health within Healthcare Innovation, connecting the industry classification with the people and institutions currently showing activity. It gives context from 148 gurus across 170 stocks, so the feed can be read as an industry-level signal rather than a loose list of single-stock events.
GLP-1 & Metabolic Health Smart Money Notes
Maduck SeanSee Remarks
Sell $1.5M of disclosed value in Corcept Therapeutics Incorporated $CORT.
Sell
Dambkowski CarlDirector
Sell $6.2M of disclosed value in Oruka Therapeutics, Inc. $ORKA.
Sell
Maduck SeanSee Remarks
Sell $4.9M of disclosed value in Corcept Therapeutics Incorporated $CORT.
Sell
Foundation Fighting Blindness Retinal Degeneration FundInstitutional Owner
Sell $7.4M of disclosed value in Opus Genetics, Inc. $IRD.
Sell
Barlow Jeff D.CLO
Sell $3.3M of disclosed value in Molina Healthcare Inc $MOH.
Sell
Fairmount Funds Management LLC10% Owner
Buy $20.0M of disclosed value in Viridian Therapeutics, Inc.DE $VRDN.
Buy
Orbimed Advisors LLC10% Owner
Buy $5M of disclosed value in Traws Pharma, Inc. $TRAW.
Buy
Leonard Braden Michael10% Owner
Sell $1.4M of disclosed value in Aclaris Therapeutics, Inc. $ACRS.
Sell
Maizel AriCCO
Sell $1.4M of disclosed value in Axsome Therapeutics, Inc. $AXSM.
Sell
Bodenstedt MatthiasCFO
Sell $1.6M of disclosed value in MoonLake Immunotherapeutics $MLTX.
Sell
Kirk Randal JDirector, 10% Owner
Sell $15.5M of disclosed value in Precigen, Inc. $PGEN.
Sell
Ra Capital Management, L.p.Institutional Owner
Buy $8.8M of disclosed value in Mineralys Therapeutics, Inc. $MLYS.
Buy
Oep VII Gp, L.l.c.10% Owner
Buy $24.3M of disclosed value in AdaptHealth Corp. - Class A $AHCO.
Buy
Belanoff Joseph KDirector, CEO
Sell $1.3M of disclosed value in Corcept Therapeutics Incorporated $CORT.
Sell
Collins Helen LouiseCMO
Sell $1.4M of disclosed value in Enliven Therapeutics, Inc. $ELVN.
Sell
Balcom AlexandraCFO
Sell $2.5M of disclosed value in Nuvalent, Inc. $NUVL.
Sell
Cashin Richard M Jr10% Owner
Buy $4.4M of disclosed value in AdaptHealth Corp. - Class A $AHCO.
Buy
Peetz ChristopherDirector, CEO
Sell $3.8M of disclosed value in Mirum Pharmaceuticals, Inc. $MIRM.
Sell
Pelish Henry E.CSO
Sell $2.9M of disclosed value in Nuvalent, Inc. $NUVL.
Sell
Radovich PeterPresident, COO
Sell $1.5M of disclosed value in Mirum Pharmaceuticals, Inc. $MIRM.
Sell
Cashin Richard M Jr10% Owner
Buy $19.9M of disclosed value in AdaptHealth Corp. - Class A $AHCO.
Buy
Lange Louis GDirector
Sell $1.3M of disclosed value in NewAmsterdam Pharma Company N.V. $NAMS.
Sell
Bernstein HaroldPresident, R, D, CMO
Sell $1.5M of disclosed value in Maze Therapeutics, Inc. $MAZE.
Sell
Kastelein Johannes Jacob PieterDirector, CSO
Sell $9.1M of disclosed value in NewAmsterdam Pharma Company N.V. $NAMS.
Sell
Tang KevinDirector
Buy $4.2M of disclosed value in Aurinia Pharmaceuticals Inc. $AUPH.
Buy
Jacobson Mark L.COO
Sell $5.7M of disclosed value in Axsome Therapeutics, Inc. $AXSM.
Sell
Davidson Michael H.Director, CEO
Sell $9.4M of disclosed value in NewAmsterdam Pharma Company N.V. $NAMS.
Sell
Coleman MarkDirector
Sell $4.0M of disclosed value in Axsome Therapeutics, Inc. $AXSM.
Sell
Murphy Patrick MichaelCBO, CLO
Sell $1.1M of disclosed value in iRhythm Technologies, Inc. $IRTC.
Sell
Showing 31-60 of 226